Jon S. Saxe, Director at SCICLONE PHARMACEUTICALS INC (SCLN), bought 15,000 shares at $1.89 ($28K) on 2007-11-20, disclosed to the SEC on 2007-11-23.
Open-market purchase of $28k SCLN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.88 | 913 | $2K | 6.0% |
| 2 | $1.89 | 200 | $378 | 1.3% |
| 3 | $1.90 | 8,887 | $17K | 59.4% |
| 4 | $1.87 | 200 | $374 | 1.3% |
| 5 | $1.89 | 3,792 | $7K | 25.2% |
| 6 | $1.90 | 1,008 |
| $2K |
| 6.7% |
| Total | $1.90 avg | 15,000 | $28K | 100% |
| Filing → |
| DRRX | BUY | 2019-05-28 | $19K | — | Filing → |
| DRRX | BUY | 2019-05-15 | $7K | — | Filing → |
| DRRX | BUY | 2019-05-14 | $55K | — | Filing → |